Expert Review of Neurotherapeutics, Volume 21, Issue 1 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Neurotherapeutics, Volume 21, Issue 1 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Anesthesia for electroconvulsive therapy during the COVID-19 pandemic
Elaine Loureiro Pereira-Soares, Antonio Leandro Nascimento, Jorge Adelino da Silva & Antonio Egidio Nardi
Pages: 1-3
Published online: 18 Oct 2020
First Page PreviewforAnesthesia for electroconvulsive therapy during the COVID-19 pandemic | Full Text | References | PDF (160.2 KB) | EPUB
  • 1850 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Is there value in using randomized placebo controlled trials in neuromuscular disease?
John R. Bach, Giulio Chiarello, William Weiss & Nizar Souayah
Pages: 5-7
Published online: 19 Oct 2020
First Page PreviewforIs there value in using randomized placebo controlled trials in neuromuscular disease? | Full Text | References | PDF (158.2 KB) | EPUB
  • 1063 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Drug profile

Article
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia
Benjamin J. Dorfman & Joohi Jimenez-Shahed
Pages: 9-20
Published online: 23 Nov 2020
AbstractforDeutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia | Full Text | References | PDF (484.4 KB) | EPUB
  • 205 Views
  • 6 CrossRef citations
  • 0Altmetric

Review

Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?
Giancarlo Comi, Gloria Dalla Costa & Lucia Moiola
Pages: 21-34
Published online: 10 Oct 2020
AbstractforNewly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials? | Full Text | References | PDF (478.4 KB) | EPUB
  • 460 Views
  • 6 CrossRef citations
  • 0Altmetric
Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges
Prerna Chauhan, Ashish Kumar Kakkar, Harmanjit Singh & C. S. Gautam
Pages: 35-43
Published online: 05 Nov 2020
AbstractforMinocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges | Full Text | References | PDF (357 KB) | EPUB
  • 113 Views
  • 6 CrossRef citations
  • 0Altmetric
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system
Sarah Demaré, Asha Kothari, Nigel A. Calcutt & Paul Fernyhough
Pages: 45-63
Published online: 04 Dec 2020
AbstractforMetformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system | Full Text | References | PDF (4.4 MB) | EPUB
  • 6864 Views
  • 36 CrossRef citations
  • 0Altmetric
Open Access
Acute ischemic stroke management: concepts and controversies.A narrative review
Ka Hou Christien Li, Aaron Jesuthasan, Christopher Kui, Ruth Davies, Gary Tse & Gregory Y. H. Lip
Pages: 65-79
Published online: 02 Nov 2020
AbstractforAcute ischemic stroke management: concepts and controversies.A narrative review | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 517 Views
  • 15 CrossRef citations
  • 0Altmetric
Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders
Cécile Delorme, Camille Giron, David Bendetowicz, Aurélie Méneret, Louise-Laure Mariani & Emmanuel Roze
Pages: 81-97
Published online: 08 Nov 2020
AbstractforCurrent challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders | Full Text | References | PDF (6.3 MB) | EPUB
  • 354 Views
  • 10 CrossRef citations
  • 0Altmetric
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome
Simona Lattanzi, Gaetano Zaccara, Emilio Russo, Angela La Neve, Monica Anna Maria Lodi & Pasquale Striano
Pages: 99-110
Published online: 25 Oct 2020
AbstractforPractical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 539 Views
  • 18 CrossRef citations
  • 0Altmetric
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges
Shahid Hussain, Prashant K. Jamwal, Paulette V. Vliet & Nicholas A. T. Brown
Pages: 111-121
Published online: 16 Nov 2020
AbstractforRobot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges | Full Text | References | PDF (1.7 MB) | EPUB
  • 797 Views
  • 16 CrossRef citations
  • 0Altmetric

Original Research

Article
Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients
Enrique Martínez-Pías, David García-Azorín, Ane Minguez-Olaondo, Javier Trigo, Álvaro Sierra, Marina Ruiz & Ángel L. Guerrero
Pages: 123-130
Published online: 02 Nov 2020
AbstractforTriptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients | Full Text | References | PDF (1.8 MB) | EPUB
  • 93 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting
Huah Shin Ng, Feng Zhu, Elaine Kingwell, Yinshan Zhao, Shenzhen Yao, Okechukwu Ekuma, Lawrence W Svenson, Charity Evans, John D. Fisk, Ruth Ann Marrie & Helen Tremlett
Pages: 131-140
Published online: 09 Dec 2020
AbstractforCharacteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting | Full Text | References | PDF (316.1 KB) | EPUB
  • 172 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Current use of neurotoxins for alleviating symptoms of cervical dystonia
Stephen Aradi et al.
Review Article | Published online: 19 Jun 2024
Mindfulness as a therapeutic option for obsessive-compulsive disorder
Andreas Reis et al.
Report | Published online: 18 Jun 2024
Open Access
Rethinking the role of trazodone in the different depressive dimensions
Isabella Berardelli et al.
Comment | Published online: 17 Jun 2024
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions
Abdullah H. Ishaque et al.
Review Article | Published online: 16 Jun 2024
View all latest articles